Lecture Notes: Carbapenems and Monobactams
Overview
- Lecturer: Dr. Rowe
- Main Focus: Carbapenems
- Additional Topic: Monobactams
- Both are classifications of beta-lactam antibiotics, similar to penicillins and cephalosporins.
Monobactams
- Primary Monobactam: Aztreonam
- Narrow-spectrum antibiotic
- Effective against Pseudomonas
- Relevant for studying antibiotic resistance
Carbapenems
- Examples:
- Imipenem
- Meropenem
- Doripenem
- Characteristics:
- Broad-spectrum antibiotics
- Resistant to beta-lactamase enzymes
- Broadest spectrum among beta-lactams
- Effective against many Gram-negative bacteria
Usage and Resistance
-
Usage:
- Broad-spectrum nature means they are widely used
- Often used in a "shotgun approach" for unknown infections
-
Resistance:
- High usage leads to increased bacterial resistance
- Carbapenem-resistant Enterobacteriaceae (CRE) are a significant concern
- CRE includes organisms like Shigella, Klebsiella, E. coli, and Pseudomonas
- CRE are often resistant to all but one antibiotic: colistin
Issues and Concerns
-
Imipenem Example:
- Often combined with cilastatin to prevent rapid breakdown in kidneys
- Historically effective against over 90% of hospital pathogens
- Effectiveness is slowly decreasing
-
CRE Organisms:
- Known as "superbugs"
- Resistant to multiple drug types
- If also resistant to colistin, treatment options become extremely limited
- Current treatment success rate is low; 50% mortality for bloodstream infections
Future Challenges
Conclusion
- The importance of understanding carbapenems given their current effectiveness and the looming threat of antibiotic resistance.
- Optimism for future solutions in antibiotic development or alternatives.
Note: Stay informed and understand the significance of antibiotic resistance and the critical role of carbapenems in current medical treatments.